Author

Richard N Cassidy

Van Andel InstituteORCID 0000-0002-1148-0068Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:chromatin & epigenetic regulation· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1

Frequent Co-Authors

Wesley N. SaintilnordiD· 2 shared Yvonne N. Fondufe‐MittendorfiD· 2 shared Andrew PymaniD· 1 shared Daniël P. MeltersiD· 1 shared Darrell P. ChandleriD· 1 shared Darrell P. Chandler· 1 shared Élisson Nogueira LopesiD· 1 shared Héjer DhahriiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Wesley N. SaintilnordORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell Communication and SignalingPeer-reviewedJun 24, 2026

SATB2 and circ3915 RNA chromatin dysregulation drive KRAS-like oncogenic transformation

Rebekah Eleazer, Smitha George, Luke J. Shoemaker…·Yvonne N. Fondufe‐Mittendorf

This study shows that SATB2 and circ3915 RNA chromatin dysregulation can drive KRAS-like oncogenic transformation in lung epithelial cells without driver mutations.

1 citation

humanChIP-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 18, 2024

Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programs

Wesley N. Saintilnord, Youssef A. Hegazy, Kristin V Chesnutt…·Yvonne N. Fondufe‐Mittendorf

This study shows that H2B variants alter chromatin structure and oncogenic gene expression, suggesting they may be early cancer biomarkers and therapeutic targets.

5 citations

humanATAC-seq

𝕏 PostBluesky